D.A. Davidson & CO. lifted its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 3.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,294 shares of the financial services provider’s stock after buying an additional 671 shares during the quarter. D.A. Davidson & CO.’s holdings in MetLife were worth $1,839,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC lifted its stake in MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC boosted its stake in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. purchased a new position in MetLife during the third quarter worth about $30,000. Finally, Fortitude Family Office LLC increased its stake in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares during the last quarter. 89.81% of the stock is owned by institutional investors.
MetLife Trading Down 0.0 %
NYSE:MET opened at $88.23 on Friday. The company has a fifty day moving average of $83.34 and a 200 day moving average of $76.59. MetLife, Inc. has a 52 week low of $63.02 and a 52 week high of $89.05. The firm has a market capitalization of $61.09 billion, a P/E ratio of 17.79, a P/E/G ratio of 0.81 and a beta of 1.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on MET shares. StockNews.com raised MetLife from a “hold” rating to a “buy” rating in a report on Monday, November 25th. Jefferies Financial Group raised their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Wells Fargo & Company upped their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Barclays lowered their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Thursday, October 31st. Finally, TD Cowen upped their price objective on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday. Fourteen research analysts have rated the stock with a buy rating, According to MarketBeat.com, MetLife currently has an average rating of “Buy” and a consensus target price of $88.62.
View Our Latest Research Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- Stock Analyst Ratings and Canadian Analyst Ratings
- MarketBeat Week in Review – 11/25 – 11/29
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.